We are live on
!
Find out more
AUTL
Autolus Therapeutics
AUTL
AUTL
46 hedge funds and large institutions have $344M invested in Autolus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
250% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 6
31% more funds holding
Funds holding: 35 → 46 (+11)
2.49% more ownership
Funds ownership: 45.05% → 47.54% (+2.5%)
40% less capital invested
Capital invested by funds: $569M → $344M (-$225M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
46
Holders Change
+11
Holders Change %
+31.43%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
21
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$23.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.36M |
| 4 |
Millennium Management
New York
|
+$7.1M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$6.32M |
